Loading...
Loading...
India's fluticasone imports from BRAZIL total $8.7M across 16 shipments from 2 foreign suppliers. DERMA&DERMO COM.PRODS.DERM.FARM.LTDA(AMHO) leads with $8.7M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include SITEC LABS LIMITED. This corridor reflects India's pharmaceutical import demand for fluticasone — a concentrated sourcing relationship with select suppliers from BRAZIL.

DERMA&DERMO COM.PRODS.DERM.FARM.LTDA(AMHO) is the leading Fluticasone supplier from BRAZIL to India, with import value of $8.7M across 9 shipments. The top 5 suppliers — DERMA&DERMO COM.PRODS.DERM.FARM.LTDA(AMHO), GLOBAL ORGANIZACAO FARMACEUTICA LIMITEDA — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DERMA&DERMO COM.PRODS.DERM.FARM.LTDA(AMHO) | $8.7M | 9 | 100.0% |
| 2 | GLOBAL ORGANIZACAO FARMACEUTICA LIMITEDA | $2.7K | 7 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SITEC LABS LIMITED | $8.6M | 3 | 99.8% |
| 2 | CIPLA LIMITED | $18.0K | 13 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Fluticasone suppliers from BRAZIL to India include DERMA&DERMO COM.PRODS.DERM.FARM.LTDA(AMHO), GLOBAL ORGANIZACAO FARMACEUTICA LIMITEDA. The leading supplier is DERMA&DERMO COM.PRODS.DERM.FARM.LTDA(AMHO) with import value of $8.7M USD across 9 shipments. India imported Fluticasone worth $8.7M USD from BRAZIL in total across 16 shipments.
India imported Fluticasone worth $8.7M USD from BRAZIL across 16 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Fluticasone sourced from BRAZIL include SITEC LABS LIMITED, CIPLA LIMITED. The largest buyer is SITEC LABS LIMITED with $8.6M in imports across 3 shipments.
The total value of Fluticasone imports from BRAZIL to India is $8.7M USD, across 16 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists